Shanghai Bao Pharma Sets 28 Aug 2026 Board Meeting to Review H1 Results

Bulletin Express

08/18

Shanghai Bao Pharmaceuticals Co., Ltd. announced that its Board of Directors will convene on Friday, 28 August 2026. The meeting’s primary agenda is to review and approve the interim financial results for the six months ended 30 June 2026 and authorize their subsequent publication. Additional matters may also be considered during the session.

The Board is currently composed of Executive Directors Dr. Liu Yanjun (Chairman), Ms. Wang Zheng and Ms. Li Cui; Employee Representative Director Mr. Sun Yuhua; Non-Executive Directors Ms. Lin Chia-ling, Mr. Diao Juanhuan and Mr. Li Chen; and Independent Non-Executive Directors Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen and Mr. Zhang Senquan.

The company released the notice from its Shanghai headquarters on 18 August 2026, underscoring procedural transparency ahead of its mid-year earnings disclosure.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1171121109"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1171121109\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1171121109?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171121109","market":"us","top_or_hot":-1,"title":"Shanghai Bao Pharma Sets 28 Aug 2026 Board Meeting to Review H1 Results","media":"Bulletin Express","content":"<p>Shanghai Bao Pharmaceuticals Co., Ltd. announced that its Board of Directors will convene on Friday, 28 August 2026. The meeting’s primary agenda is to review and approve the interim financial results for the six months ended 30 June 2026 and authorize their subsequent publication. Additional matters may also be considered during the session.</p>\n<p>The Board is currently composed of Executive Directors Dr. Liu Yanjun (Chairman), Ms. Wang Zheng and Ms. Li Cui; Employee Representative Director Mr. Sun Yuhua; Non-Executive Directors Ms. Lin Chia-ling, Mr. Diao Juanhuan and Mr. Li Chen; and Independent Non-Executive Directors Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen and Mr. Zhang Senquan.</p>\n<p>The company released the notice from its Shanghai headquarters on 18 August 2026, underscoring procedural transparency ahead of its mid-year earnings disclosure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Bao Pharma Sets 28 Aug 2026 Board Meeting to Review H1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Bao Pharma Sets 28 Aug 2026 Board Meeting to Review H1 Results\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-18 16:48</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shanghai Bao Pharmaceuticals Co., Ltd. announced that its Board of Directors will convene on Friday, 28 August 2026. The meeting’s primary agenda is to review and approve the interim financial results for the six months ended 30 June 2026 and authorize their subsequent publication. Additional matters may also be considered during the session.</p>\n<p>The Board is currently composed of Executive Directors Dr. Liu Yanjun (Chairman), Ms. Wang Zheng and Ms. Li Cui; Employee Representative Director Mr. Sun Yuhua; Non-Executive Directors Ms. Lin Chia-ling, Mr. Diao Juanhuan and Mr. Li Chen; and Independent Non-Executive Directors Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen and Mr. Zhang Senquan.</p>\n<p>The company released the notice from its Shanghai headquarters on 18 August 2026, underscoring procedural transparency ahead of its mid-year earnings disclosure.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02659","symbol_name":"寶濟藥業-B","start_time":0,"source_url":"","article_id":"1171121109","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171121109","pubTimestamp":1787042895,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Bao Pharmaceuticals Co., Ltd. announced that its Board of Directors will convene on Friday, 28 August 2026. The meeting’s primary agenda is to review and approve the interim financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02659":"宝济药业-B"},"translate_title":"上海宝医药定于 2026 年 8 月 28 日召开董事会审查上半年业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1},"content_text":"Shanghai Bao Pharmaceuticals Co., Ltd. announced that its Board of Directors will convene on Friday, 28 August 2026. The meeting’s primary agenda is to review and approve the interim financial results for the six months ended 30 June 2026 and authorize their subsequent publication. Additional matters may also be considered during the session.\nThe Board is currently composed of Executive Directors Dr. Liu Yanjun (Chairman), Ms. Wang Zheng and Ms. Li Cui; Employee Representative Director Mr. Sun Yuhua; Non-Executive Directors Ms. Lin Chia-ling, Mr. Diao Juanhuan and Mr. Li Chen; and Independent Non-Executive Directors Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen and Mr. Zhang Senquan.\nThe company released the notice from its Shanghai headquarters on 18 August 2026, underscoring procedural transparency ahead of its mid-year earnings disclosure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}